Found 5 clinical trials
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer
This phase I trial studies the side effects and best dose of vandetanib and everolimus when given together in treating patients with cancer that has spread to other places in the body
- 0 views
- 28 Jun, 2021
- 1 location
Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
previously treated with cabozantinib or vandetanib who have tumors with rearranged-during-transfection (RET) mutations and have tumors without RET mutations.
- 0 views
- 24 May, 2021
- 1 location
A Phase I Dose Escalation Study for Patients With Recurrent Malignant Gliomas
the study is to find out the highest dose of vandetanib that can be safely given with repeat radiation therapy. Vandetanib will be called "study drug" in the remainder of this consent form
- 7 views
- 07 Nov, 2020
- 1 location
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
The purpose of this study is to evaluate the efficacy and feasibility of combination chemotherapy with target agents according to the result of targeted deep sequencing in pediatric patients with relapsed/refractory solid tumor or AML.
- 0 views
- 24 Jan, 2021
- 1 location
Natural History Study of Children and Adults With Medullary Thyroid Cancer
Background Medullary thyroid cancer (MTC) is a rare cancer of the thyroid gland. In children and adults, it is often part of a condition called Multiple Endocrine Neoplasia 2 (MEN2). MEN2 is usually caused by a genetic mutation, and it can cause a number of problems in addition to MTC. …
- 0 views
- 12 Sep, 2021
- 1 location